120 related articles for article (PubMed ID: 38385211)
21. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
[TBL] [Abstract][Full Text] [Related]
22. Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: a retrospective cohort study.
Kwon RJ; Park EJ; Lee SY; Lee Y; Hwang C; Kim C; Cho YH
Lipids Health Dis; 2021 Sep; 20(1):104. PubMed ID: 34511128
[TBL] [Abstract][Full Text] [Related]
23. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
26. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
27. Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.
Zhu GD; OuYang S; Liu F; Zhu ZG; Jiang FN; Zhang B
Ann Clin Lab Sci; 2017 Nov; 47(6):657-662. PubMed ID: 29263038
[TBL] [Abstract][Full Text] [Related]
28. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
29. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
[TBL] [Abstract][Full Text] [Related]
30. Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer.
Kaur A; Elzagheid A; Birkman EM; Avoranta T; Kytölä V; Korkeila E; Syrjänen K; Westermarck J; Sundström J
Cancer Med; 2015 Dec; 4(12):1798-808. PubMed ID: 26377365
[TBL] [Abstract][Full Text] [Related]
31. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
[TBL] [Abstract][Full Text] [Related]
32. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract][Full Text] [Related]
34. Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis.
Peng J; Ou Q; Guo J; Pan Z; Zhang R; Wu X; Zhao Y; Deng Y; Li C; Wang F; Li L; Chen G; Lu Z; Ding P; Wan D; Fang Y
Aging (Albany NY); 2017 Nov; 9(11):2334-2351. PubMed ID: 29135454
[TBL] [Abstract][Full Text] [Related]
35. Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis.
Krieg A; Werner TA; Verde PE; Stoecklein NH; Knoefel WT
PLoS One; 2013; 8(6):e65338. PubMed ID: 23755220
[TBL] [Abstract][Full Text] [Related]
36. High MICB expression as a biomarker for good prognosis of colorectal cancer.
Feng Q; Yu S; Mao Y; Ji M; Wei Y; He G; Chang W; Zhu D; Ren L; Xu J
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1405-1413. PubMed ID: 32306128
[TBL] [Abstract][Full Text] [Related]
37. CircRNA VPRBP inhibits tumorigenicity of cervical cancer via miR-93-5p/FRMD6 axis.
Shen L; Dang J; Liu S; Xian B; Deng Y; Qu D
Reprod Sci; 2022 Aug; 29(8):2251-2264. PubMed ID: 35501594
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
[TBL] [Abstract][Full Text] [Related]
39. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
Wang Z; Jiang B; Chen L; Di J; Cui M; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Dong B; Ji J; Su X
J Transl Med; 2014 Jan; 12():15. PubMed ID: 24444035
[TBL] [Abstract][Full Text] [Related]
40. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C
Oncology; 2021; 99(12):790-801. PubMed ID: 34515203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
